🫀 When a rare perfusion emergency strikes, is your team prepared? This editorial explores why protocols should be living resources—not static documents. 🔗 imrpress.com/journal/HSF/29/… #CardiacSurgery #Perfusion #PatientSafety #ECMO

A 68-year-old with severe degenerative mitral regurgitation (MR). Society of Thoracic Surgeons (STS) risk: low. Would you offer: A. Robotic mitral repair B. Mini-thoracotomy repair C. Full sternotomy repair What would you choose? 👇 read: imrpress.com/journal/HSF/29/… #CardiacSurgery

We are pleased to share that 9 Editorial Board Members of The Heart Surgery Forum were featured in the World’s Top 2% Scientists 2026 list. We are deeply grateful to our editorial board members for their dedication and expertise🫀 #Top2Scientists #CardiacSurgery

🫀 Beyond surgery: how does heart disease shape a child’s life? A systematic review and meta-analysis highlights the impact of pediatric heart disease on cognitive function, neurodevelopment, and quality of life. #PediatricCardiology #CHD #QualityOfLife imrpress.com/journal/HSF/28/…

🫀 A new non-invasive model combines TFC, E/e′ ratio, and LVEF to assess pulmonary congestion in heart failure patients with permanent atrial fibrillation. read: imrpress.com/journal/HSF/28/… #HeartFailure #Cardiology

🫀 A failed mitral repair does not always mean the end of treatment options. This case highlights the use of transcatheter mitral valve-in-ring replacement with a novel Renato valve in a high-risk patient with recurrent mitral regurgitation and severe LV dysfunction. #Cardiology

🫀 Balancing protection and bleeding after TAVR This study examines how dual antiplatelet therapy affects bleeding, transfusion, and long-term outcomes following transcatheter aortic valve replacement.

🧬Not all #cardiomyopathies look the same A rare case of Danon disease revealed an unexpected phenotype: arrhythmogenic right ventricular cardiomyopathy (ARVC) Genetic testing identified a novel LAMP2 variant, expanding the known cardiac spectrum of this rare disorder #Cardiology

🫀 A tumor outside the heart can damage the heart valves. Carcinoid heart disease develops when bioactive substances from neuroendocrine tumors cause cardiac valve fibrosis. is essential for improving patient care. #Cardiology #ValvularHeartDisease #CardioOncology

🫀 Beyond the numbers: the story behind a 23-year emergency CABG study Dr. Kieran Strong shares his perspectives on surgical training, unexpected findings, and how large-scale data can help shape the future of cardiac surgery. 👇 imrpress.com/journal/HSF/pag… #CardiacSurgery #CABG